awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33368188-8D6B4BF7-7F34-4CCC-90F7-D38797FC68C2
Q33368188-8D6B4BF7-7F34-4CCC-90F7-D38797FC68C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33368188-8D6B4BF7-7F34-4CCC-90F7-D38797FC68C2
Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial.
P2860
Q33368188-8D6B4BF7-7F34-4CCC-90F7-D38797FC68C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33368188-8D6B4BF7-7F34-4CCC-90F7-D38797FC68C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4375e870127d59a7cf05b0cf86d53b21e709891d
P2860
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.